Public Companies
Red Light Holland: Substantial Revenue Increase And Streamlined Operational Performance In Fiscal 2023
Red Light Holland Corp. (OTC: TRUFF), the functional mushroom company with a psychedelic twist, reported audited annual financial statements for fiscal…
Red Light Holland Corp. (OTC: TRUFF), the functional mushroom company with a psychedelic twist, reported audited annual financial statements for fiscal 2023. It was record year of growth—including 5-digit percentage growth in certain divisions.
For the year, Red Light Holland produced record revenue of $3.95 million, which was an 69.8% increase over the $2.33 million generated in 2022. The rise in ‘wholesale mushroom sales’ was by far the greatest contributor to this gain, growing an astounding 10,998% year-over-year, while ‘mushroom grow kit sales’ increased 218.86%, in part to the acquisition of Minichamp (see below). Core ‘wholesale product sales’ remained stable, with a small increase in fiscal 2023 revenues.
Wholesale mushroom sales grew 10,998% year-over-year in fiscal 2023, Source: Red Light Holland Consolidated Financial Statements for the years ended March 31, 2023 and 2022
Interestingly, the higher revenue occurred despite a twenty-nine percent (28.96%) decrease in operating expenses. If we exclude share-based compensation, the revenue bump still came amid a 2.85% decrease in remaining OpEx. This would generally be considered a positive trend towards operational efficiency.
Operating expenses refer to the costs incurred in running the day-to-day business ...
Full story available on Benzinga.com
psychedelic mushroom otc red light holland-
Law & Regulation6 days ago
FDA to weigh safety, impact of MDMA therapy for PTSD at June meeting
-
Psilocybin1 week ago
The Psychedelic Scene in Oaxaca, Mexico
-
Psychedelics1 week ago
Numinus Wellness Focused on Boosting Profitability and Expanding Community Support
-
Psychedelics1 week ago
MindMed Reports First Quarter 2024 Financial Results and Business Updates
-
Psychedelics1 week ago
Oprah Daily’s Comprehensive Guide to Psychedelics: A Milestone for Industry Acceptance
-
Psychedelics1 week ago
Lophos Pharmaceuticals Corp. Enters Into Letter of Intent to Acquire the Assets of Magicactus.com
-
Ketamine1 week ago
Reunion Neuroscience raises $103 million
-
Psychedelics1 week ago
Lophos Pharmaceuticals Corp. Enters Into Letter of Intent to Acquire the Assets of Magicactus.com